Supplementary Figure S2 from Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

<p>Figure S2: Features of glioblastoma models used to assess therapeutic potential of EdU. The features in red are less than desirable, blue are moderately desirable, and green are ideal. As such, the compounds were tested on multiple cell culture platforms to supplement the weaknesses of indi...

詳細記述

保存先:

書誌詳細
第一著者:	Humeyra Kaanoglu (21903844) (author)
その他の著者:	Adebimpe Adefolaju (21903847) (author), Casey Fraley (21903850) (author), Mariah Shobande (21903853) (author), Rajaneekar Dasari (21903856) (author), Breanna Mann (21903859) (author), Noah Bell (21903862) (author), Stephen T. Keir (18724623) (author), Dominique Higgins (21903865) (author), David E. Kram (15110825) (author), Shawn D. Hingtgen (21903868) (author), Aziz Sancar (21903871) (author), Andrew B. Satterlee (21903874) (author)
出版事項:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology CNS Cancers Gliomas, Glioblastomas Dna Damage And Repair DNA damage Precision Medicine Preclinical Models Small Molecule Agents Translational Research
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Supplementary Figure S2 from Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

類似資料